Efficacy and Safety of Ruxolitinib Cream by Anatomic Region in Children Aged 2 to 11 Years With Atopic Dermatitis: Results From TRuE-AD3. J of Skin. 2024;8(6):s453. doi:10.25251/skin.8.supp.453